ライフサイエンスコーパス: T-cell leukemia

1 (prostate), MDA-MB-231 (breast), and Jurkat (T-cell leukemia).

2 a spectrum of human malignancies, including T cell leukemia.

3 d retroviruses with the former causing adult T cell leukemia.

4 pathy/tropical spastic paraparesis and adult T cell leukemia.

5 ons in both the induction and maintenance of T cell leukemia.

6 perturbation of its activity often leads to T cell leukemia.

7 and MAPK kinase activities in CD3-activated T cell leukemia.

8 ll lines and dampens global transcription in T cell leukemia.

9 ackfan anemia (DBA), congenital asplenia and T cell leukemia.

10 of thymocytes, and subsequent generation of T-cell leukemia.

11 ors was associated with improved outcomes in T-cell leukemia.

12 e 1 (HTLV-1) is the causative agent of adult T-cell leukemia.

13 humans and is etiologically linked to adult T-cell leukemia.

14 cell transformation and development of adult T-cell leukemia.

15 event in the process of ZNF198-FGFR1-induced T-cell leukemia.

16 irus type-1 is the causative agent for adult T-cell leukemia.

17 nt of the aggressive and fatal disease adult T-cell leukemia.

18 1 (HTLV-1) is the etiological agent of adult T-cell leukemia.

19 infects CD4+ T lymphocytes and causes adult T-cell leukemia.

20 rus may play a role in the etiology of adult T-cell leukemia.

21 I (HTLV-1) is the etiological agent of adult T-cell leukemia.

22 onses in the majority of patients with adult T-cell leukemia.

23 1 (HTLV-1) is the etiologic agent for adult T-cell leukemia.

24 investigate the role of this interaction in T-cell leukemia.

25 ed ribosomal mutation in acute lymphoblastic T-cell leukemia.

26 y reduced in CD19(+) spleen B cells from Emu-T cell leukemia 1 (TCL1) transgenic mice relative to the

27 tudies revealed that ROR1 could complex with T-cell leukemia 1 (TCL1) in CLL, we crossed these animal

28 The T-cell leukemia 1 (TCL1) oncoprotein is overexpressed by

29 T-cell leukemia 1 (TCL1), the AKT modulator and proto-on

30 T-cell leukemia 1A (TCL1A) was the gene closest (926-700

31 The T cell leukemia 3 (Tlx3) gene has been implicated in spe

32 tained diseases, such as autoimmunity, adult T cell leukemia and HIV-1.

33 ogenesis related to the progression of adult T cell leukemia and HTLV-1-associated myelopathy/tropica

34 ntrolled tumor growth in xenograft models of T cell leukemia and pancreatic cancer.

35 ic virus type 1 (HTLV-1) mainly causes adult T cell leukemia and predominantly immortalizes/transform

36 genetic aberrations that promote acute B and T cell leukemias and the mechanisms of cell transformati

37 r different cancer cell lines, in this case, T-cell leukemia and B-cell lymphoma.

38 A056 selectively targets acute lymphoblastic T-cell leukemia and cutaneous T-cell lymphoma.

39 e 1 (HTLV-1) is the causative agent of adult T-cell leukemia and HTLV-1-associated myelopathy/tropica

40 virus type 1 (HTLV-1) infection causes adult T-cell leukemia and is associated with a variety of lymp

41 mature lymphocytes, develop multiple B- and T-cell leukemia and lymphoma subtypes, supporting an onc

42 -1), an etiological factor that causes adult T-cell leukemia and lymphoma, has a crucial role in init

43 ntial therapeutic agent for the treatment of T-cell leukemia and lymphoma.

44 enic mutations in NOTCH1 are common in human T-cell leukemia and lymphomas.

45 There are 3 categories: chronic T-cell leukemia and NK-cell lymphocytosis, which are sim

46 virus type 1 (HTLV-1) infection causes adult T-cell leukemia and several lymphocyte-mediated inflamma

47 kemia virus type 1 (HTLV-1)-associated adult T-cell leukemia and T-cell lymphoma (ATL) are aggressive

48 with several serious diseases, such as adult T-cell leukemia and tropical spastic paraparesis/myelopa

49 ry tumor virus (MMTV) variant, often induces T-cell leukemias and lymphomas by c-myc activation follo

50 est that FBW7 is a novel tumor suppressor in T cell leukemia, and implicate the loss of FBW7 function

51 Patients who have T-cell leukemia appear to have a better outcome with all

52 and constitutive Notch signaling potentiates T cell leukemia as well as Drosophila neuroblast tumors.

53 BZ is important for the development of adult T-cell leukemia associated with HTLV-1 infection.

54 All R26-betacat mice develop T-cell leukemias at 5 to 6 months of age.

55 of pathologic abnormalities, including adult T cell leukemia (ATL) and HTLV-1-associated myelopathy/t

56 Adult T cell leukemia (ATL) is a serious form of cancer with a

57 pontaneous proliferation of smoldering adult T cell leukemia (ATL) T cells.

58 fatal hematopoietic malignancy termed adult T cell leukemia (ATL).

59 1 (HTLV-1) is the etiological agent of adult T-cell leukemia (ATL) and HTLV-1-associated myelopathy/t

60 e 1 (HTLV-1) is the causative agent of adult T-cell leukemia (ATL) and HTLV-1-associated myelopathy/t

61 Adult T-cell leukemia (ATL) and human T-cell lymphotropic viru

62 s-1 (HTLV-I) is the etiologic agent of adult T-cell leukemia (ATL) and the neurological disorder HTLV

63 oup that first identified a cluster of adult T-cell leukemia (ATL) cases in Japan, provided conclusiv

64 -1)-transformed lymphocyte cell lines, adult T-cell leukemia (ATL) cells, and in other hematologic ma

65 In most adult T-cell leukemia (ATL) cells, Tax oncoprotein expression

66 Adult T-cell leukemia (ATL) is a fatal malignancy caused by in

67 Adult T-cell leukemia (ATL) is an aggressive malignancy of CD4

68 Adult T-cell leukemia (ATL) is an aggressive T-cell malignancy

69 Adult T-cell leukemia (ATL) is caused by human T-cell lymphotr

70 The etiologic agent of adult T-cell leukemia (ATL) is human T cell lymphotropic virus

71 Adult T-cell leukemia (ATL), a heterogeneous disease, can be d

72 s are implicated in the development of adult T-cell leukemia (ATL), a T-cell malignancy caused by HTL

73 rus type 1 (HTLV-I) is associated with adult T-cell leukemia (ATL), an aggressive lymphoproliferative

74 e-I (HTLV-I) is the etiologic agent of adult T-cell leukemia (ATL), an aggressive lymphoproliferative

75 irus type 1 (HTLV-1) that recapitulate adult T-cell leukemia (ATL)-like leukemic symptoms and display

76 1 (HTLV-I) is the etiological agent of adult T-cell leukemia (ATL).

77 nic retrovirus etiologically causal of adult T-cell leukemia (ATL).

78 hat induces a fatal T-cell malignancy, adult T-cell leukemia (ATL).

79 sidered to be the etiological agent of adult T-cell leukemia (ATL).

80 orldwide and is the causative agent of adult T-cell leukemia (ATL).

81 use a rare form of leukemia designated adult T-cell leukemia (ATL).

82 etrovirus and the etiological agent of Adult T-cell Leukemia (ATLL).

83 f amphibian lymphocytes and the Jurkat human T cell leukemia cell line.

84 distinct signaling proteins in a panel of 13 T-cell leukemia cell lines treated with a gamma-secretas

85 Consistently, human adult T cell leukemia cells that acquire elevated APC(Cdc20) a

86 histone deacetylase 2 in erythroleukemia and T cell leukemia cells.

87 GBP with selective cytotoxicity toward human T-cell leukemia cells and indicate its potential use in

88 zomib (an agent whose cytotoxicity in Jurkat T-cell leukemia cells is dependent on Noxa) was examined

89 ol for the incubation of Jurkat (human acute T-cell leukemia) cells with Ac5ManNTGc and the quantitat

90 ked to a spectrum of diverse diseases: adult T cell leukemia, encephalomyelopathy, and predisposition

91 tudies, performed in translational models of T cell leukemia, establish a mechanism-based rationale f

92 HTLV) type 1, the etiological agent of adult T-cell leukemia, expresses the viral oncoprotein Tax1.

93 s in vitro and iNKT-cell-mediated control of T-cell leukemia growth in vivo.

94 This systems biology analysis defined T cell leukemia homeobox 1 (TLX1) and TLX3 as master reg

95 oncogene (encoding the transcription factor T cell leukemia homeobox protein-1) has a major role in

96 n proposed to have tumor suppressor roles in T-cell leukemia homeobox 1/3-transformed human T-ALL cel

97 NA binding site for the poorly characterized T-cell leukemia homeobox 3 (TLX3) TF was confirmed with

98 LIM homeobox transcription factor 1 beta and T-cell leukemia homeobox 3.

99 transduction pathway, commonly activated in T-cell leukemia in both mouse and man.

100 opoietic stem cell transplantation for adult T-cell leukemia in Japan.

101 ell leukemia virus 1 (HTLV-1)-mediated adult T cell leukemia is associated with the ability of viral

102 ood, Nagai et al provide evidence that adult T-cell leukemia is hierarchically organized and sustaine

103 leukemia virus type 1 (HTLV-1)-induced adult T-cell leukemia is linked to the expression of the viral

104 lective and potent cytotoxicity toward human T-cell leukemia Jurkat cells compared with a panel of ca

105 A CRISPR screen conducted in a CD4(+) T cell leukemia line has identified host factors require

106 he induction of apoptosis in Jurkat cells, a T-cell leukemia line.

107 , pTa, Gata3, and Runx1, in both Ikaros null T cell leukemia lines and Ikaros null primary thymocytes

108 a lifelong infection and is linked to adult T-cell leukemia lymphoma (ATLL).

109 BZ) could be used for immunotherapy in adult T-cell leukemia-lymphoma (ATL) patients.

110 odification of host gene expression in adult T-cell leukemia-lymphoma (ATL).

111 d natural killer cell lymphoma and for adult T-cell leukemia-lymphoma.

112 kemia virus type 1 (HTLV-1)-associated adult T cell leukemia/lymphoma (ATL) cells as a model system.

113 Adult T cell leukemia/lymphoma (ATL) is an aggressive cancer o

114 Adult T cell leukemia/lymphoma (ATLL) is an aggressive maligna

115 In adult T cell leukemia/lymphoma (ATLL), the FoxP3(+) population

116 Deregulation of the T cell leukemia/lymphoma 1 (TCL1) oncogene in mouse B ce

117 ype 1 (HTLV-1) is a causative agent of adult T cell leukemia/lymphoma and a variety of inflammatory d

118 e 1 (HTLV-1) is the causative agent of adult T cell leukemia/lymphoma.

119 ical spastic paraparesis (HAM/TSP) and adult T cell leukemia/lymphoma.

120 virus type 1 (HTLV-1) infection causes adult T-cell leukemia/lymphoma (ATL) and is associated with a

121 d with the lymphoproliferative disease adult T-cell leukemia/lymphoma (ATL) and the neurodegenerative

122 In adult T-cell leukemia/lymphoma (ATL) cell lines and patient T

123 Adult T-cell leukemia/lymphoma (ATL) is an aggressive and fata

124 Adult T-cell leukemia/lymphoma (ATL) is etiologically linked t

125 -cell leukemia virus type 1-associated adult T-cell leukemia/lymphoma (ATL) typically has survivals m

126 sactivator initiates transformation in adult T-cell leukemia/lymphoma (ATL), a highly aggressive chem

127 e 1 (HTLV-1) is the causative agent of adult T-cell leukemia/lymphoma (ATL), a malignancy of CD4(+) T

128 lts in a variety of diseases including adult T-cell leukemia/lymphoma (ATL).

129 leukemia (3), hairy cell leukemia (1), adult T-cell leukemia/lymphoma (ATLL) (1), marginal zone leuke

130 ), anaplastic large-cell lymphoma, and adult T-cell leukemia/lymphoma (ATLL) and a lower incidence of

131 r A (RHOA) hotspot mutations among the adult T-cell leukemia/lymphoma (ATLL) category have opposite b

132 Adult T-cell leukemia/lymphoma (ATLL) is an incurable disease

133 In IL-2-dependent cells and adult T-cell leukemia/lymphoma (ATLL) patient samples, however

134 ic virus type-1 (HTLV-1) that initiate adult T-cell leukemia/lymphoma (ATLL) remain unclear, in part

135 We recently reported the first case of adult T-cell leukemia/lymphoma (ATLL) that responded rapidly t

136 CD8(+) T cells, yet this virus causes adult T-cell leukemia/lymphoma (ATLL) that typically has a CD4

137 e 1 (HTLV-1) is the etiologic agent of adult T-cell leukemia/lymphoma (ATLL).

138 astic type (18.5%), NKTCL (10.4%), and adult T-cell leukemia/lymphoma (ATLL; 9.6%).

139 T-cell leukemia/lymphoma 1 (TCL1) is an oncogene overexp

140 ouse studies indicate that activation of the T-cell leukemia/lymphoma 1 (TCL1) oncogene is a contribu

141 mmon human leukemia and dysregulation of the T-cell leukemia/lymphoma 1 (TCL1) oncogene is a contribu

142 The T-cell leukemia/lymphoma 1 (TCL1) oncogene is a target o

143 Here, we determined whether T-cell leukemia/lymphoma 1 (TCL1) oncoprotein encoded by

144 Deregulation of the T-cell leukemia/lymphoma 1 oncogene (TCL1) in mouse B ce

145 ive anaplastic large cell lymphoma, 14 adult T-cell leukemia/lymphoma and 44 extranodal NK/T-cell lym

146 e 1 (HTLV-1) is the causative agent of adult T-cell leukemia/lymphoma and HTLV-1-associated myelopath

147 causes two distinct pathologies termed adult T-cell leukemia/lymphoma and tropical spastic paraparesi

148 virus type 1 (HTLV-1) is the cause of adult T-cell leukemia/lymphoma as well as tropical spastic par

149 To study the impact of oncogenic K-Ras on T-cell leukemia/lymphoma development and progression, we

150 l recognized as a potential factor for adult T-cell leukemia/lymphoma development.

151 Adult T-cell leukemia/lymphoma has a homogeneous molecular sig

152 Adult T-cell leukemia/lymphoma is a fatal malignancy etiologic

153 The p12(I) protein of human T-cell leukemia/lymphoma virus type 1 (HTLV-1) is a smal

154 The human T-cell leukemia/lymphoma virus type 1 (HTLV-1) ORF-I enc

155 The human T-cell leukemia/lymphoma virus type 1 (HTLV-1) p30 prote

156 logically linked to infection with the human T-cell leukemia/lymphoma virus type 1 (HTLV-I).

157 The persistence of human T-cell leukemia/lymphoma virus-I (HTLV-I)-infected cells

158 1 (HTLV-1) is the etiological agent of adult T-cell leukemia/lymphoma, and it encodes a number of non

159 l lymphoma, cutaneous T-cell lymphoma, adult T-cell leukemia/lymphoma, and other peripheral T-cell ly

160 ided highly diverse results on the issues of T-cell leukemia/lymphoma-initiating cells (T-LICs) and p

161 ts a major risk for the development of adult T-cell leukemia/lymphoma.

162 lastic large-cell lymphoma (ALCL), and adult T-cell leukemia/lymphoma.

163 e resulted in a highly penetrant, aggressive T-cell leukemia/lymphoma.

164 proliferation, which in turn leads to adult T-cell leukemia/lymphoma.

165 duced many elements of HTLV-associated adult T-cell leukemia/lymphoma.

166 d from patients with HTLV-I-associated adult T-cell leukemia or with progeria.

167 ferent human cancers including lymphoblastic T-cell leukemia, pancreatic cancer, melanoma and rhabdom

168 eripheral blood mononuclear cells from adult T-cell leukemia patients.

169 usative agents for cervical cancer and adult T-cell leukemia, respectively.

170 Adult patients with acute lymphoblastic T cell leukemia (T-ALL) have a very poor prognosis and f

171 nsmembrane protein highly expressed in acute T-cell leukemia (T-ALL) and in a subset of peripheral T-

172 ly in primary and secondary tissues, we used T-cell leukemia (TCL)1 cells reactive with the autoantig

173 An age of 10 years or older, T-cell leukemia, the presence of an 11q23 rearrangement,

174 The orf-I gene of human T-cell leukemia type 1 (HTLV-1) encodes p8 and p12 and h

175 The effects that human T cell leukemia virus (HTLV) type 1 and simian immunodef

176 The etiology of human T cell leukemia virus 1 (HTLV-1)-mediated adult T cell l

177 Ectopic expression of human T cell leukemia virus 1-encoded Tax protein, which resem

178 Infection by human T cell leukemia virus type 1 (HTLV-1) causes a fatal hem

179 Human T cell leukemia virus type 1 (HTLV-1) has evolved a rema

180 Human T cell leukemia virus type 1 (HTLV-1) inhibits host anti

181 Human T cell leukemia virus type 1 (HTLV-1) is associated with

182 The human T cell leukemia virus type 1 (HTLV-1) is the causative a

183 Human T cell leukemia virus type 1 (HTLV-1) is the etiologic a

184 Human T cell leukemia virus type 1 (HTLV-1), also known as hum

185 ced apoptosis, we used TRAIL-resistant human T cell leukemia virus type 1 (HTLV-1)-associated adult T

186 cytes) to the total viral burden in 22 human T cell leukemia virus type 1 (HTLV-1)-infected individua

187 Human T cell leukemia virus type 1 and type 2 (HTLV-1 and -2)

188 Retroviral Tax proteins from human T cell leukemia virus type 1 and type 2 (HTLV-1 and -2)

189 Furthermore, the Tax oncoprotein of human T cell leukemia virus type I targeted this complex for i

190 l virus, human immunodeficiency virus, human T cell leukemia virus, human papilloma virus, hepatitis

191 Human T cell leukemia virus, type 1 (HTLV-1) replication and s

192 recognizes the foreign Ag Tax from the human T cell leukemia virus-1 when presented by the class I MH

193 sible link with the autoimmune disease human T cell leukemia virus-1-associated myelopathy/tropical s

194 Human T-cell leukemia virus (HTLV) regulatory protein, Rex, fu

195 The human T-cell leukemia virus (HTLV) type 1 transcriptional tran

196 Human T-cell leukemia virus (HTLV) type 1, the etiological age

197 ly discovered the antisense protein of human T-cell leukemia virus (HTLV) type 2 (APH-2), whose messe

198 ntification of the genes necessary for human T-cell leukemia virus (HTLV-1) persistence in humans may

199 logically linked to infection with the human T-cell leukemia virus (HTLV-1).

200 cation and partial characterization of human T-cell leukemia virus (HTLV; now known as HTLV-1) produc

201 A role for microRNAs (miRNA) in human T-cell leukemia virus 1 (HTLV-1)-mediated cellular trans

202 Ubiquitination of the human T-cell leukemia virus 1 Tax oncoprotein provides an impo

203 12-O-Tetradecanoylphorbol-13-acetate, human T-cell leukemia virus 1 Tax, and CD40 did not.

204 Infection with human T-cell leukemia virus induces cellular genomic instabili

205 t of important human pathogens such as human T-cell leukemia virus type 1 (HTLV-1) and HIV-1.

206 Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 are clo

207 ence techniques in real time with both human T-cell leukemia virus type 1 (HTLV-1) and human immunode

208 Human T-cell leukemia virus type 1 (HTLV-1) and type 2 (HTLV-2

209 Human T-cell leukemia virus type 1 (HTLV-1) and type 2 (HTLV-2

210 Human T-cell leukemia virus type 1 (HTLV-1) basic leucine zipp

211 et al report that vaccination against human T-cell leukemia virus type 1 (HTLV-1) basic leucine zipp

212 Infection with human T-cell leukemia virus type 1 (HTLV-1) can cause a rare f

213 ally integrated form of the retrovirus human T-cell leukemia virus type 1 (HTLV-1) contains identical

214 rs proposed a model for this region of human T-cell leukemia virus type 1 (HTLV-1) Env in which expul

215 Human T-cell leukemia virus type 1 (HTLV-1) establishes a life

216 iculoendotheliosis virus A (REV-A) and human T-cell leukemia virus type 1 (HTLV-1) exhibit PCE activi

217 nt data showing that neither HIV-1 nor human T-cell leukemia virus type 1 (HTLV-1) expresses signific

218 Human T-cell leukemia virus type 1 (HTLV-1) expression depends

219 PPY motif in the matrix (MA) domain of human T-cell leukemia virus type 1 (HTLV-1) Gag associates wit

220 Human T-cell leukemia virus type 1 (HTLV-1) has two late domai

221 Human T-cell leukemia virus type 1 (HTLV-1) infection and tran

222 Human T-cell leukemia virus type 1 (HTLV-1) infection causes a

223 ut the ability of NK cells to restrain human T-cell leukemia virus type 1 (HTLV-1) infection.

224 Human T-cell leukemia virus type 1 (HTLV-1) is a complex retro

225 Human T-cell leukemia virus type 1 (HTLV-1) is a retrovirus as

226 Human T-cell leukemia virus type 1 (HTLV-1) is a retrovirus th

227 Human T-cell leukemia virus type 1 (HTLV-1) is a retrovirus, a

228 Surprisingly, the NC protein from human T-cell leukemia virus type 1 (HTLV-1) is an extremely po

229 Human T-cell leukemia virus type 1 (HTLV-1) is an oncogenic re

230 Human T-cell leukemia virus type 1 (HTLV-1) is an oncogenic re

231 ablished that cell-free infection with human T-cell leukemia virus type 1 (HTLV-1) is less efficient

232 Transcriptional activation of human T-cell leukemia virus type 1 (HTLV-1) is mediated by the

233 The particle structure of human T-cell leukemia virus type 1 (HTLV-1) is poorly characte

234 Human T-cell leukemia virus type 1 (HTLV-1) is the causative a

235 The complex retrovirus human T-cell leukemia virus type 1 (HTLV-1) is the causative a

236 Human T-cell leukemia virus type 1 (HTLV-1) is the causative a

237 The human T-cell leukemia virus type 1 (HTLV-1) is the cause of ad

238 Human T-cell leukemia virus type 1 (HTLV-1) is the etiologic a

239 Human T-cell leukemia virus type 1 (HTLV-1) is the etiological

240 Human T-cell leukemia virus type 1 (HTLV-1) is the etiological

241 Infection by the human T-cell leukemia virus type 1 (HTLV-1) is thought to caus

242 d, Fujikawa et al demonstrate that the human T-cell leukemia virus type 1 (HTLV-1) oncoprotein Tax in

243 In the present study, we show that the Human T-cell Leukemia Virus Type 1 (HTLV-1) oncoprotein Tax is

244 uggested to be largely dispensable for human T-cell leukemia virus type 1 (HTLV-1) particle biogenesi

245 ecently shown to bind and activate the human T-cell leukemia virus type 1 (HTLV-1) promoter at bases

246 The role of autophagy in human T-cell leukemia virus type 1 (HTLV-1) replication has, h

247 Human T-cell leukemia virus type 1 (HTLV-1) Tax affects cellul

248 The human T-cell leukemia virus type 1 (HTLV-1) Tax oncoprotein ac

249 -risk human papillomavirus (HPV) E6 or human T-cell leukemia virus type 1 (HTLV-1) Tax oncoproteins.

250 lishment of humanized mice infected by human T-cell leukemia virus type 1 (HTLV-1) that recapitulate

251 The glycoproteins from human T-cell leukemia virus type 1 (HTLV-1) were resistant to

252 In comparison, NC of human T-cell leukemia virus type 1 (HTLV-1), a deltaretrovirus

253 The retroviral oncoprotein Tax from human T-cell leukemia virus type 1 (HTLV-1), an etiological fa

254 udy, we found that HBZ, encoded by the Human T-cell Leukemia Virus type 1 (HTLV-1), binds to multiple

255 of the deltaretroviruses, for example, human T-cell leukemia virus type 1 (HTLV-1), have been evaluat

256 , which can result from infection with human T-cell leukemia virus type 1 (HTLV-1), is associated wit

257 infection by HIV-1, HIV-1Deltavif, and human T-cell leukemia virus type 1 (HTLV-1), while significant

258 Human T-cell leukemia virus type 1 (HTLV-1)-associated adult T

259 The etiology of human T-cell leukemia virus type 1 (HTLV-1)-induced adult T-ce

260 Disease development in human T-cell leukemia virus type 1 (HTLV-1)-infected individua

261 aggressive T-cell malignancy caused by human T-cell leukemia virus type 1 (HTLV-1).

262 mediates transcriptional activation of human T-cell leukemia virus type 1 (HTLV-1).

263 infection with the complex retrovirus human T-cell leukemia virus type 1 (HTLV-1).

264 Human T-cell leukemia virus type 1 (HTLV-I) is associated with

265 Human T-cell leukemia virus type 1 (HTLV-I) is the etiological

266 s level of BIC by up to 70% in EBV- or human T-cell leukemia virus type 1 (HTLV1)-transformed cell li

267 The human T-cell leukemia virus type 1 oncoprotein Tax has pleiotr

268 The Tax oncoprotein encoded by the human T-cell leukemia virus type 1 plays a pivotal role in vir

269 De novo expression of human T-cell leukemia virus type 1 Tax results in cellular gen

270 Unlike the resistance of HIV-1 and human T-cell leukemia virus type 1 to hA3G, the resistance of

271 ion of additional human tumor viruses--human T-cell leukemia virus type 1, hepatitis C virus, and Kap

272 Human T-cell leukemia virus type 1-associated adult T-cell leu

273 Human T-cell leukemia virus type 1-infected cells proliferate

274 uman immunodeficiency virus type 1 and human T-cell leukemia virus type 1.

275 viruses in the transplant population: human T-cell leukemia virus type 1; hepatitis E virus; bocavir

276 Human T-cell leukemia virus type 2 (HTLV-2) Rex is a transacti

277 Human T-cell leukemia virus type I (HTLV-1) is the etiological

278 Human T-cell leukemia virus type I (HTLV-1) replication relies

279 Human T-cell leukemia virus type I (HTLV-I) encodes a Tax onco

280 The Human T-cell leukemia virus type I (HTLV-I) is the only known

281 The mechanisms by which the human T-cell leukemia virus type I (HTLV-I) Tax oncoprotein de

282 Human T-cell leukemia virus type I (HTLV-I)-associated maligna

283 Reports have shown that Tax, a human T-cell leukemia virus type I encoded protein that has be

284 date tumor suppressor, is repressed in human T-cell leukemia virus type-1 (HTLV-1)-transformed lympho

285 Human T-cell leukemia virus type-1 is the causative agent for

286 o nucleosomal templates containing the human T-cell leukemia virus type-1 promoter sequences.

287 nduces a severe telomere shortening in human T-cell leukemia virus type-1-infected cells which signal

288 Human T-cell leukemia virus type-I (HTLV-I) is the etiologic a

289 Human T-cell leukemia virus type-I expresses Tax, a 40-kDa onc

290 Human T-cell leukemia virus types 3 and 4 (HTLV-3 and HTLV-4)

291 teract with the C terminus of Tax-1 of human T-cell leukemia virus with micromolar affinity.

292 Infection with the human T-cell leukemia virus-1 (HTLV-1) results in a variety of

293 The human T-cell leukemia virus-encoded oncoprotein Tax is a poten

294 omain are highly conserved among the primate T cell leukemia viruses, but this extension is absent in

295 em cells (HSCs) and B cells, and that causes T-cell leukemia when overexpressed.

296 sease onset in murine models of Notch-driven T-cell leukemia, whether Dicer1-processed miRNAs are ess

297 ted mAb by immunizing mice with Jurkat acute T cell leukemia, which binds ILT3.Fc to its membrane.

298 vating IKK, yet only HTLV-1 infection causes T cell leukemia, which correlates with persistent activa

299 Adult T-cell leukemia, which can result from infection with hu

300 HTLV-1 mainly causes adult T cell leukemia, while HTLV-2 is not associated with leu

301 These data indicate that patients with T-cell leukemia with K-Ras mutations may benefit from th